Alteration of Transcriptomic Profile and Antiseptic Efficacy of Adipose-Derived Mesenchymal Stromal/Stem Cells Under Different Culture Conditions
Stem Cells and Development · 01.02.2023 · 32 (3-4) · 75-86
DOI: 10.1089/scd.2022.0238 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cells and Development, erschienen am 01.02.2023. Verfasst von Chen Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Regenerative Medicine Research Center, Sichuan University West China Hospital, Chengdu, China. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Sepsis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Regenerative Medicine Research Center, Sichuan University West China Hospital, Chengdu, China.
- Tennessee Institute of Regenerative Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
ORCID-Profile: Y James Kang
Zitieren
APA
Chen, C., Hou, X., Jing, F., Wang, T., Feng, L., & Kang, Y. J. (2023). Alteration of Transcriptomic Profile and Antiseptic Efficacy of Adipose-Derived Mesenchymal Stromal/Stem Cells Under Different Culture Conditions. Stem Cells and Development, 32(3-4), 75-86. https://doi.org/10.1089/scd.2022.0238
Vancouver
Chen C, Hou X, Jing F, Wang T, Feng L, Kang YJ. Alteration of Transcriptomic Profile and Antiseptic Efficacy of Adipose-Derived Mesenchymal Stromal/Stem Cells Under Different Culture Conditions. Stem Cells and Development. 2023;32(3-4):75-86. doi:10.1089/scd.2022.0238
BibTeX
@article{Chen2023,
author = {Chen, Chen and Hou, Xiaoming and Jing, Fujia and Wang, Tao and Feng, Li and Kang, Y James},
title = {Alteration of Transcriptomic Profile and Antiseptic Efficacy of Adipose-Derived Mesenchymal Stromal/Stem Cells Under Different Culture Conditions},
journal = {Stem Cells and Development},
year = {2023},
volume = {32},
number = {3-4},
pages = {75--86},
doi = {10.1089/scd.2022.0238}
}
EUVIMED